Form 4: Enfusion Director Michael Spellacy Reports Disposal of Shares Following Merger with Clearwater Analytics

Director Michael Spellacy reports the disposal of Enfusion shares following the completion of a merger with Clearwater Analytics, marking his exit filing.

Summary

• Michael Spellacy, a director of Enfusion, Inc., filed a Form 4 to report changes in beneficial ownership of Enfusion securities.
• The report indicates that Spellacy disposed of 56,810 shares of Class A Common Stock due to the merger agreement between Enfusion and Clearwater Analytics Holdings, Inc.
• The merger consideration included cash, shares of Clearwater Analytics Class A common stock, or a combination of both, at the election of the shareholder.
• As a result of the merger, Spellacy no longer beneficially owns any securities of Enfusion, marking this as his exit filing.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a merger, so the sentiment is neutral.

Future Outlook

The document does not contain any specific forward-looking statements regarding the future of Clearwater Analytics or the merged entity.

Industry Context

The merger reflects a trend of consolidation in the financial technology sector, where companies seek to expand their product offerings and market reach through strategic acquisitions.

Comparison to Industry Standards

• Comparing the merger to similar transactions in the financial technology sector, the consideration structure involving cash and stock is a common approach.
• Other comparable companies that have been involved in mergers include firms like SS&C Technologies and FactSet, which have also grown through acquisitions to offer a broader suite of services.

Key Dates

Keywords

Enfusion, Clearwater Analytics, Merger, Form 4, Beneficial Ownership, Spellacy, Director, Shares, Stock